30.07.2012
- Novartis drug Afinitor, expected to become a major seller for the Swiss drugmaker, was approved by European regulators to treat women with a certain type of breast cancer, the...
27.07.2012
- Merck & Co reported better-than-expected quarterly earnings on strong sales of vaccines and treatments for diabetes and HIV, giving investors greater faith the company can weather...
27.07.2012
- A U.S. Food and Drug Administration panel on Thursday recommended two drugs for combating different forms of vision loss that can lead to blindness among a range of adults...
27.07.2012
- Amgen on Thursday reported far higher-than-expected second-quarter profit and revenue on strong demand for many of its drugs, and the world's largest biotechnology company raised...
26.07.2012
- Europe's sick economy is infecting its pharmaceuticals sector, traditionally one of the region's most successful industries. Price cuts to rein in healthcare spending reached...
26.07.2012
- Swiss drugmaker Roche Holding took $1.7 billion in restructuring charges it said should lead to big savings as it confirmed its outlook on Thursday with first-half sales beating...
25.07.2012
- GlaxoSmithKline warned on Wednesday that sales in 2012 would be flat as pressure on drug prices intensifies in Europe, due to government austerity measures aimed at curbing...
25.07.2012
- Swiss drug industry supplier Lonza confirmed its profit guidance on Wednesday and said demand in its key business remained strong despite macroeconomic uncertainties. The Basel...
